Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 13 Sept 2007 |
| Genmab Discloses Target and Development Plans for HuMax-Inflam | 13 Sept 2007 |
| Genmab Provides Insights into IgG4 Antibodies | 13 Sept 2007 |
| Genmab Announces Encouraging Preclinical Data for Ofatumumab | 7 Sept 2007 |
| Genmab to Attend Three September Investor Conferences | 3 Sept 2007 |